image
Healthcare - Biotechnology - NASDAQ - US
$ 2.98
-0.334 %
$ 178 M
Market Cap
-3.97
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
-0.00%
Net Income Estimate
--80.07%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Eledon Pharmaceuticals, Inc.
image
ELDN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ELDN

image
$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ELDN

image
$40.0m$40.0m$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ELDN

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)20232023202420242025202520262026202720272028202820292029